These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 6805144)

  • 1. [Activation of the antihemophilic globulin A (factor VIII). 2. Effect of ampholine on the course of blood coagulation and the molecular conformation of factor VIII].
    Liebe S
    Z Gesamte Inn Med; 1982 Feb; 37(4):110-6. PubMed ID: 6805144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Activation of antihemophilic globulin A (factor VIII). 1. Activation by ampholine].
    Liebe S; Thierbach B
    Z Gesamte Inn Med; 1982 Feb; 37(4):105-10. PubMed ID: 6805143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of ampholines on blood coagulation: 1. Activation of factor VIII (antihemophilic globulin A)].
    Liebe S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(4):454-61. PubMed ID: 54294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Increase of in vitro factor VIII activity by polyaminopolycarboxylic acid].
    Drawert J; Stein P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(6):914-8. PubMed ID: 6162758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Activation of the antihemophilic globulin A (factor VIII). 3. Activation by servalyte].
    Liebe S; Wegner H
    Z Gesamte Inn Med; 1982 Mar; 37(5):153-5. PubMed ID: 6805146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of phospholipid reagents used in coagulation I: some general properties and their sensitivity to factor VIII.
    Barrowcliffe TW; Gray E
    Thromb Haemost; 1981 Oct; 46(3):629-33. PubMed ID: 6797093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of human factor VIII. III. Transitions between forms of factor VIII present in cryoprecipitate and in cryosupernatant plasma.
    Over J; Bouma BN; Sixma JJ; Bolhuis PA; Vlooswijk RA
    J Lab Clin Med; 1980 Mar; 95(3):323-34. PubMed ID: 7354239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical and chemical properties of normal and haemophilic factor VIII.
    Vermylen J
    Pathol Biol (Paris); 1975 Dec; 23 suppl():5-10. PubMed ID: 772559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The factor VIII complex: structure and function.
    Hoyer LW
    Prog Clin Biol Res; 1981; 72():1-26. PubMed ID: 6801681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Importance of PPSB fraction in the treatment of hemophilia A with antibodies against factor VIII].
    Hrubisková K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(4):672-82. PubMed ID: 6162735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent antihaemophilic activity of basic amphoteric polyelectrolytes.
    Exner T; Rickard KA; Kronenberg H
    Aust J Exp Biol Med Sci; 1978 Apr; 56(2):169-76. PubMed ID: 678227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationships of factor VIII (antihemophilic globulin) and its weak inhibitors with the spleen. Effect of adrenaline on splenectomized subjects, on splenomegaly and on patients presenting a weak factor VIII inhibitor].
    Mayer G; Kalogjera V; Oberling F; Mayer S; Waitz R
    Haematol Lat; 1971; 13(3):185-206. PubMed ID: 5097059
    [No Abstract]   [Full Text] [Related]  

  • 13. [Production of factor VIII preparations and their use in the substitution therapy of hemophilia A].
    Gaerisch F; Stein P
    Z Gesamte Inn Med; 1982 Oct; 37(19):641-4. PubMed ID: 6817530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The dosage of antihemophilic globulin, or antihemophilic plasma as well as Cohn's fraction I in factor VIII deficiency].
    Hrubisková K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(3):363-8. PubMed ID: 4195283
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of factor VII on the assay of factor VIII by the one stage method using wettable surface.
    Altman R; Rouvier J; Reussi C
    Thromb Diath Haemorrh; 1972 Dec; 28(3):457-63. PubMed ID: 4675266
    [No Abstract]   [Full Text] [Related]  

  • 16. The immunological properties of factor VIII. I. Studies on the inhibitory activity of specific antisera to human antihemophilic globulin.
    Uszyński L
    Thromb Diath Haemorrh; 1966 Dec; 16(3):558-73. PubMed ID: 5301276
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro kinetics of factor VIII activity in patients with mild haemophilia A and a discrepancy between one-stage and two-stage factor VIII assay results.
    Rodgers SE; Duncan EM; Barbulescu DM; Quinn DM; Lloyd JV
    Br J Haematol; 2007 Jan; 136(1):138-45. PubMed ID: 17222201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A modification of a method of evaluating the coagulation activity of factor VIII].
    Levchenko LB; Papaian LP; Kotovshchikova MA; Khrolova PV
    Lab Delo; 1989; (5):22-5. PubMed ID: 2473253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The type of factor VIII deficient plasma used influences the performance of the Nijmegen modification of the Bethesda assay for factor VIII inhibitors.
    Verbruggen B; Giles A; Samis J; Verbeek K; Mensink E; Novákovà I
    Thromb Haemost; 2001 Dec; 86(6):1435-9. PubMed ID: 11776311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration.
    Mosnier LO; Lisman T; van den Berg HM; Nieuwenhuis HK; Meijers JC; Bouma BN
    Thromb Haemost; 2001 Oct; 86(4):1035-9. PubMed ID: 11686321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.